The battle against malaria in Africa is far from over, and the urgency of the situation demands a comprehensive and coordinated response. As the Director General of Africa CDC, H.E. Dr. Jean Kaseya, highlights, the continent's struggle with malaria is not merely a health crisis but a significant obstacle to Africa's development and sovereignty. With an estimated 270.8 million cases and nearly 600,000 deaths in 2024, malaria continues to cast a long shadow over the continent's progress.
The progress made in the past two decades, including the widespread use of insecticide-treated nets, indoor residual spraying, and the introduction of the malaria vaccine, has undoubtedly saved countless lives. However, the fragility of these gains cannot be overlooked. Recent reports indicate a resurgence of malaria cases, with artemisinin partial resistance emerging as a significant concern. This resistance threatens the long-term effectiveness of first-line treatments, underscoring the need for innovative and adaptive strategies.
One of the critical challenges, as Dr. Kaseya emphasizes, is the strength of the systems delivering essential commodities. The availability of resources is no longer the primary issue; instead, it is the capacity of countries to rapidly, precisely, and equitably implement prevention, diagnosis, treatment, surveillance, and response measures. This is where the concept of Africa's Health Security and Sovereignty (AHSS) agenda comes into play.
In my opinion, the AHSS agenda is not just about having the right tools but also about having the robust systems to utilize them effectively. It requires a holistic approach, including strengthening public health institutions, building resilient and digitally enabled primary health care systems, and ensuring effective surveillance and laboratory support. By doing so, Africa can truly claim health sovereignty, where a preventable disease does not continue to claim hundreds of thousands of lives annually.
To address these challenges, Africa CDC is taking several strategic actions. Firstly, they are mobilizing high-level political commitment from African leaders, recognizing the importance of their support in translating continental and global strategies into local actions. This involves advocating for political will to drive consistent and context-specific interventions.
Secondly, Africa CDC is focusing on evidence generation. They are deepening their understanding of emerging threats, such as artemisinin partial resistance and the impact of climate change on transmission patterns. By combining routine program data, research, and advanced analytics, they aim to provide actionable insights tailored to diverse epidemiological contexts. This evidence-based approach will enable countries to make informed decisions and adapt their strategies accordingly.
The establishment of the African Malaria Response Acceleration Taskforce (AMRAT) is a significant step in this direction. By leveraging the Incident Management Support Team (IMST) model, AMRAT will coordinate response efforts, strengthen accountability, and improve results. It will address bottlenecks, support the deployment of interventions, and monitor resistance, ensuring a more cohesive and effective response across the continent.
Furthermore, Africa CDC is emphasizing the importance of community-based systems. By mobilizing the remaining 1 million community health workers, they aim to improve program efficiency, timely course correction, and data utilization. Digitally enabled and climate-resilient primary health care systems will empower these workers, forming the backbone of accelerated malaria control and elimination. This approach also integrates malaria interventions with other health services, such as maternal and child health, nutrition, and immunization.
The availability and accessibility of malaria commodities are another critical aspect. Africa CDC is advocating for local manufacturing and establishing reliable markets through the Africa Pooled Procurement Mechanism (APPM). This initiative has already shown success with the production of bed nets in Angola, ensuring a more sustainable supply chain.
In conclusion, the fight against malaria in Africa requires a multi-faceted approach. It demands political commitment, evidence-based decision-making, strong community engagement, and investments in local manufacturing and commodity accessibility. By treating malaria as a defining test of Africa's Health Security and Sovereignty, the continent can take control of its public health future. It is time for Africa to end malaria, not just aspire to do so. The lives of hundreds of thousands of people depend on it, and the continent's development and sovereignty are at stake.
